Abstract
Helicobacter pylori infection (HPI) imposes substantial social costs and is of major etiological importance in peptic ulcer disease, gastric cancer, and accelerated cardiovascular diseases. This study determined the risk of acute coronary syndrome (ACS) associated with HPI in a nationwide retrospective cohort study. By using the Taiwan National Health Insurance Research Database (NHIRD), we identified patients diagnosed with HPI from 1998 to 2010. In addition, we randomly selected non-HPI controls frequency-matched by age, sex, and index year from the general population free of HPI. The risk of ACS was analyzed using Cox proportional hazards regression models in which sex, age, and comorbidities were included as variables. We identified 17,075 participants for the HPI group and selected 68,300 participants for the comparison group. The incidence rates were increased in the patients in the HPI group compared with those in the comparison group. Overall, the HPI patients exhibited a 1.93-fold high crude hazard ratio for ACS, and a 1.48-fold adjusted hazard ratio after age, sex, and comorbidities were adjusted. However, the overall adjusted hazard ratio of ACS increased with increasing age with a 3.11 to 8.24 adjusted hazard ratio among the various age groups. Several comorbidities, such as diabetes, hyperlipidemia, and COPD exhibited synergistic effects for ACS risk. We determined a significant association between ACS and comorbidities and provide evidence to encourage clinicians to observe ACS-related comorbidities.
Similar content being viewed by others
References
Directorate-General of Budget, Accounting and Statistics Executive Yuan, Republic of China (2010) Statistical yearbook of the Republic of China. Health 114
Lin YS, Liu PH, Wu LS, Chen YM, Chang CJ, Chu PH (2014) Major adverse cardiovascular events in adult congenital heart disease: a population-based follow-up study from Taiwan. BMC Cardiovasc Disord 14:38
Chang KC, Tseng MC (2003) Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 34:e219–e221
Regnström J, Jovinge S, Båvenholm P, Ericsson CG, De Faire U, Hamsten A et al (1998) Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Intern Med 243:109–13
Ongey M, Brenner H, Thefeld W, Rothenbacher D (2004) Helicobacter pylori and hepatitis a virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil 11:471–476
Lu YH, Yen HW, Lin TH, Huang CH, Lee KT, Wang WM et al (2002) Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 18:266–272
Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H (2001) Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clin Chim Acta 313:87–94
Mair J, Jaffe AS (2014) Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice? Mol Diagn Ther 18:5–15
Wang Y, Wang GZ, Rabinovitch PS, Tabas I (2014) Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circ Res 114:421–433
Grufman H, Gonçalves I, Edsfeldt A, Nitulescu M, Persson A, Nilsson M et al (2014) Plasma levels of high-sensitive C-reactive protein do not correlate with inflammatory activity in carotid atherosclerotic plaques. J Intern Med 275:127–133
Khan S, Rahman HN, Okamoto T, Matsunaga T, Fujiwara Y, Sawa T et al (2014) Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci Rep 4:4680
Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9:33–40
Brown LM (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283–97
Axon AT (2007) Relationship between Helicobacter pylori gastritis, gastric cancer and gastric acid secretion. Adv Med Sci 52:55–60
Kowalski M, Pawlik M, Konturek JW, Konturek SJ (2006) Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol 57:101–111
Elizalde JI, Gómez J, Panés J, Lozano M, Casadevall M, Ramírez J et al (1997) Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 100:996–1005
Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439
Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M (1996) Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 75:568–572
Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130–1132
Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N et al (1995) Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311:711–714
Sung KC, Rhee EJ, Ryu SH, Beck SH (2005) Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 102:411–417
Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA (2009) Helicobacter pylori infection and inflammation: implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians. J Life Sci 1:45–50
Rogha M, Dadkhah D, Pourmoghaddas Z, Shirneshan K, Nikvarz M, Pourmoghaddas M (2012) Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atheroscler 7:138–41
Hussell T, Isaacson PG, Crabtree JE, Spencer J (1996) Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 178:122–127
Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS (2003) Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 71:1755–1762
Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr (2004) Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189:1914–1920
Algood HM, Gallo-Romero J, Wilson KT, Peek RM Jr, Cover TL (2007) Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 51:577–586
Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO (2009) Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 54:1253–1256
Eskandarian R, Ghorbani R, Shiyasi M, Momeni B, Hajifathalian K, Madani M (2012) Prognostic role of Helicobacter pylori infection in acute coronary syndrome: a prospective cohort study. Cardiovasc J Afr 23:131–135
Eskandarian R, Malek M, Mousavi SH, Babaei M (2006) Association of Helicobacter pylori infection with cardiac syndrome X. Singapore Med J 47:704–706
Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H et al (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34:398–402
Longo-Mbenza B, Ngoma DV, Nahimana D, Mayuku DM, Fuele SM, Ekwanzala F et al (2008) Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa. Eur J Cardiovasc Prev Rehabil 15:503–508
Longo-Mbenza B, Nsenga JN, Mokondjimobe E, Gombet T, Assori IN, Ibara JR et al (2012) Helicobacter pylori infection is identified as a cardiovascular risk factor in central Africans. Vasc Health Risk Manag 6:455–461
D'Ugo E, Rossi S, De Caterina R (2012) Proton pump inhibitors and clopidogrel: an association to avoid? G Ital Cardiol (Rome) 13:817–826
Marshall B, Stenström B, Mendis A (2008) Helicobacter pylori: the latest in diagnosis and treatment. Aust Fam Physician 37(8):608
Budzyński J, Koziński M, Kłopocka M, Kubica JM, Kubica J (2014) Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence. Clin Res Cardiol 1–32
Fan C-T, Lin J-C, Lee C-H (2008) Taiwan Biobank: a project aiming to aid Taiwan’s transition into a biomedical island. Pharmacogenomics 9(2):235–246
Acknowledgments
This work was supported by grants from the China Medical University (CMU102-BC-2), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Health and Welfare Surcharge of Tobacco Products, and the China Medical University Hospital Cancer Research Center of Excellence (MOHW103-TD-B-111-03, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors declare that they have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Ching-Yuan Lai and Tse-Yen Yang contributed equally to this study.
Rights and permissions
About this article
Cite this article
Lai, CY., Yang, TY., Lin, CL. et al. Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 34, 69–74 (2015). https://doi.org/10.1007/s10096-014-2207-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2207-7